Patents by Inventor Bradley P. Barnett

Bradley P. Barnett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11826280
    Abstract: Lacrimal canalicular delivery systems (LCDS) and their methods of use for the delivery of implants at a specific location into the canaliculus of a subject generally include a lumen, a guide wire, and an implant. The guide wire and implant are within the lumen. When pressure is applied to the guide wire, the guide wire pushes the implant out of the lumen into a specific location into the canaliculus of a subject.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: November 28, 2023
    Assignee: The Johns Hopkins University
    Inventors: Bradley P. Barnett, Albert S. Jun
  • Publication number: 20230082320
    Abstract: An exchangeable optics system includes an intraocular base that can be fixed within an eye. The intraocular base includes one or more couplers and a supporting structure. The one or more couplers releasably couple to an exchangeable optic and can include magnetic material. The supporting structure can include haptics and a main structure that physically supports the exchangeable optic. The intraocular base can include a fixed lens within or on the main structure. The exchangeable optic can include corresponding one or more couplers, which may be formed of magnetic material.
    Type: Application
    Filed: June 13, 2022
    Publication date: March 16, 2023
    Inventor: Bradley P. Barnett
  • Patent number: 11357620
    Abstract: An exchangeable optics system includes an intraocular base that can be fixed within an eye. The intraocular base includes one or more couplers and a supporting structure. The one or more couplers releasably couple to an exchangeable optic or therapeutic and can include magnetic material. The supporting structure can include haptics and a main structure that physically supports the exchangeable optic or the therapeutic that is coupled via the one or more couplers. In some cases, the intraocular base can include a fixed lens within or on the main structure. The exchangeable optic can include corresponding one or more couplers, which may be formed of magnetic material. The therapeutic can be in the form of a magnetic particle.
    Type: Grant
    Filed: September 10, 2021
    Date of Patent: June 14, 2022
    Assignee: CALIFORNIA LASIK & EYE, INC.
    Inventor: Bradley P. Barnett
  • Publication number: 20210298762
    Abstract: Canalicular occlusion devices are described comprising an occlusive element and a memory frame comprising a memory material. The occlusive element is configured to substantially prevent fluid from flowing through portions of the canaliculus. Also disclosed are methods of occluding a canalicular system with the devices of the present invention.
    Type: Application
    Filed: July 15, 2019
    Publication date: September 30, 2021
    Inventors: Albert S Jun, Bradley P. Barnett
  • Publication number: 20210298950
    Abstract: Lacrimal canalicular delivery systems (LCDS) and their methods of use for the delivery of implants at a specific location into the canaliculus of a subject are described. LCDS generally include a lumen, a guide wire, and an implant. The guide wire and implant are within the lumen. When pressure is applied to the guide wire, the guide wire pushes the implant out of the lumen into a specific location into the canaliculus of a subject.
    Type: Application
    Filed: July 15, 2019
    Publication date: September 30, 2021
    Inventors: Bradley P. Barnett, Albert S. Jun
  • Patent number: 9220761
    Abstract: The invention features alginate and alginate lyase compositions and methods that are useful for the treatment of various conditions and diseases. The invention also provides kits and instructions for use.
    Type: Grant
    Filed: April 13, 2009
    Date of Patent: December 29, 2015
    Assignee: The John Hopkins University
    Inventors: Bradley P. Barnett, Philippe Gailloud
  • Patent number: 8772229
    Abstract: The invention provides inhibitors of ghrelin O-acyltransferase, and methods of making and using them. In some embodiments, the invention provides bisubstrate analog inhibitors of ghrelin O-acyltransferase, which can be effective in treating, for example, obesity and diabetes mellitus.
    Type: Grant
    Filed: September 18, 2009
    Date of Patent: July 8, 2014
    Assignee: The Johns Hopkins University
    Inventors: Philip A. Cole, Bradley P. Barnett, Yousang Hwang, Jef D. Boeke
  • Publication number: 20110257086
    Abstract: The invention provides inhibitors of ghrelin O-acyltransferase, and methods of making and using them. In some embodiments, the invention provides bisubstrate analog inhibitors of ghrelin O-acyltransferase, which can be effective in treating, for example, obesity and diabetes mellitus.
    Type: Application
    Filed: September 18, 2009
    Publication date: October 20, 2011
    Inventors: Philip A. Cole, Bradley P. Barnett, Yousang Hwang, Jef D. Boeke
  • Publication number: 20100080788
    Abstract: The invention features alginate and alginate lyase compositions and methods that are useful for the treatment of various conditions and diseases. The invention also provides kits and instructions for use.
    Type: Application
    Filed: April 13, 2009
    Publication date: April 1, 2010
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Bradley P. Barnett, Philippe Gailloud